The PurpleLab^® Resource Center

Featured Resources

Life Sciences

PurpleLab Presents: Using Real-World Data to Better Understand Biosimilar Adoption Variation Across Healthcare Provider Specialties

This study was run to evaluate whether provider specialty is a driver for biosimilar adoption, defined as adoption probability difference (APD). Diane Faraone, PharmD, Russell Robbins, MD, MBA, Grace Kane, MS, Douglas Londono, PhD. The US biologics market has significantly expanded in recent years; projected to reach $62 billion in prescription drug spend by 2025. Biosimilar…

Real-world trends in SARS-CoV-2 antibody levels and their link to subsequent COVID-19 in the United States

Study is to assess the SARS-CoV-2 antibody levels over time (2021-2022), measured with the Elecsys Anti-SARS-COV-2 S assay, in the real-world setting, and assess the association between them and subsequent COVID-19 outcomes. Jin, Yue; Yang, Fei; Rank, Christopher; Letovsky, Stanley; Ramge, Peter and Jochum, Simon presented a poster during ISPE 2024. The objective of this…

Life Sciences

CLEAR Claims

PurpleLab® goes further than raw claims data, by serving longitudinal patient data in combination with our no-code HealthNexus platform, to deliver on-demand insights, in minutes. HealthNexus, harmonizes the complex intersections created by the array of disparate healthcare vocabularies that annotate the factual account of a patient’s journey along with the reporting dimensions of critical need….